Ritholtz Wealth Management Reduces Stake in Agilent Technologies, Inc. $A

Ritholtz Wealth Management reduced its position in Agilent Technologies, Inc. (NYSE:A) by 33.9% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,951 shares of the medical research company’s stock after selling 1,002 shares during the period. Ritholtz Wealth Management’s holdings in Agilent Technologies were worth $230,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also recently modified their holdings of A. Stone House Investment Management LLC purchased a new position in shares of Agilent Technologies in the 1st quarter worth $30,000. Ransom Advisory Ltd purchased a new position in Agilent Technologies during the first quarter valued at $32,000. Central Pacific Bank Trust Division purchased a new position in Agilent Technologies during the second quarter valued at $33,000. Zions Bancorporation National Association UT purchased a new position in Agilent Technologies during the first quarter valued at $38,000. Finally, Costello Asset Management INC purchased a new position in Agilent Technologies during the first quarter valued at $47,000.

Agilent Technologies Price Performance

Shares of Agilent Technologies stock opened at $145.79 on Wednesday. The stock’s 50-day simple moving average is $128.72 and its 200-day simple moving average is $118.37. Agilent Technologies, Inc. has a 52 week low of $96.43 and a 52 week high of $153.84. The company has a market capitalization of $41.33 billion, a price-to-earnings ratio of 34.22, a PEG ratio of 4.67 and a beta of 1.26. The company has a quick ratio of 1.71, a current ratio of 2.25 and a debt-to-equity ratio of 0.53.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, August 27th. The medical research company reported $1.37 EPS for the quarter, meeting the consensus estimate of $1.37. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The business had revenue of $1.74 billion for the quarter, compared to the consensus estimate of $1.67 billion. During the same period in the previous year, the business earned $1.32 earnings per share. The business’s revenue was up 10.1% on a year-over-year basis. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. As a group, analysts expect that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 22nd. Stockholders of record on Tuesday, September 30th will be issued a $0.248 dividend. This represents a $0.99 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Tuesday, September 30th. Agilent Technologies’s payout ratio is 23.24%.

Wall Street Analyst Weigh In

A has been the topic of several analyst reports. TD Cowen lifted their target price on Agilent Technologies from $150.00 to $162.00 and gave the company a “buy” rating in a research report on Tuesday, October 14th. Evercore ISI lifted their target price on Agilent Technologies from $128.00 to $140.00 and gave the company an “in-line” rating in a research report on Tuesday, October 7th. UBS Group upgraded Agilent Technologies from a “neutral” rating to a “buy” rating and lifted their target price for the company from $130.00 to $170.00 in a research report on Wednesday, October 8th. Wall Street Zen upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Friday, October 3rd. Finally, Barclays lifted their target price on Agilent Technologies from $125.00 to $150.00 and gave the company an “equal weight” rating in a research report on Thursday, October 2nd. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $149.62.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.